![Jeffrey Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Davis
Gründer bei
SCO Securities LLC
Profil
Jeffrey Blaine Davis is the founder of SCO Securities LLC, founded in 1997, where he holds the title of President.
He is also the founder of SCO Financial Group LLC, founded in 1997.
Currently, Mr. Davis is the Chief Executive Officer & Director at Varian Biopharma, Inc. and a Partner at SCO Capital Partners LLC, starting in 2003.
Mr. Davis has previously worked as the President, Chief Executive Officer & Director at Varian Biopharmaceuticals, Inc. He was also a Director at MacroChem Corp.
from 2005 to 2009.
Additionally, he served as a Director at Bioenvision, Inc., Oxford Ventures, Inc., ULURU, Inc., and Virium Pharmaceuticals, Inc. From 2017 to 2018, he was the Chief Operating Officer at Abeona Therapeutics, Inc. He has also held positions at Deutsche Bank AG, HMSR, Inc., Deutsche Morgan Grenfell, Bell Laboratories, and Philips Medical Systems North America, Inc.Mr. Davis holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Boston University College of Engineering.
Aktive Positionen von Jeffrey Davis
| Unternehmen | Position | Beginn |
|---|---|---|
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Private Equity Investor | 04.11.2010 |
SCO Securities LLC | Gründer | 29.07.2011 |
Ehemalige bekannte Positionen von Jeffrey Davis
| Unternehmen | Position | Ende |
|---|---|---|
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Vorstandsvorsitzender | 01.11.2022 |
| ABEONA THERAPEUTICS INC. | Vorstandsvorsitzender | 19.09.2014 |
| ULURU INC. | Direktor/Vorstandsmitglied | 01.12.2015 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 26.02.2009 |
Oxford Ventures, Inc.
 Oxford Ventures, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 05.04.2006 |
Ausbildung von Jeffrey Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Oxford Ventures, Inc.
Oxford Ventures, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Finance |
SCO Securities LLC | |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
HMSR, Inc.
 HMSR, Inc. Medical SpecialtiesHealth Technology Develops products for blood transfusion and collection procedures | Health Technology |
Deutsche Morgan Grenfell
 Deutsche Morgan Grenfell Regional BanksFinance Provides Securities services | Finance |
Bell Laboratories
 Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
ULURU, Inc.
 ULURU, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company that develops and commercializes wound care & drug delivery systems | Health Technology |
Virium Pharmaceuticals, Inc.
 Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops and commercializes novel therapeutics | Health Technology |
Philips Medical Systems North America, Inc.
 Philips Medical Systems North America, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales diagnostic imaging systems and devices | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University College of Engineering
 Boston University College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
